The SUSTAIN-6 trial, which evaluated semaglutide in patients with type 2 diabetes at high cardiovascular risk, identified a statistically significant increase in diabetic retinopathy complications in the semaglutide group compared to placebo
Not anymore particularly in more severe patients hes ready to try to the drug sooner
Some of these drugs can be administered intravenously, topical cream, nasal spray, or oral tablets
90, item 631, as amended) Manufacturer: Seeking Health, LLC 3140 Mercer Ave Bellingham, WA 98225 (800) 547-9812 Reviews No one has written a review for this product yet
Frequency varies based on your goals
All authors had full access to the data, and all authors had final responsibility for the decision to submit for publication